Levocetirizine dihydrochloride

CAS No.: 130018-87-0
Levocetirizine dihydrochloride is a second-generation antihistamine and the active enantiomer of cetirizine, a widely used medication for allergic conditions. As a selective H₁-receptor antagonist, it effectively alleviates symptoms of allergies while minimizing side effects common to first-generation antihistamines (e.g., sedation). Below is a detailed breakdown of its properties, uses, and clinical significance.
Mechanism of Action:
Levocetirizine exerts its effects by selectively blocking peripheral H₁-histamine receptors in the body. Histamine, released during allergic reactions, binds to H₁-receptors in the skin, nose, eyes, and respiratory tract, triggering symptoms like itching, sneezing, and nasal congestion. By competitively inhibiting these receptors, levocetirizine:
Reduces vascular permeability (alleviating swelling and redness).
Suppresses neurogenic inflammation (relieving itching and sneezing).
Has minimal impact on other receptor types (e.g., muscarinic, serotonin), avoiding anticholinergic side effects (e.g., dry mouth, blurred vision).
Specification: CP/USP/EP


Quickly Inquiry